Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma

por Shek, Felix H., Fatima, Sarwat, Lee, Nikki P.
Publicado 2012

Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma

por Yeung, Bonnie H. Y., Shek, Felix H., Lee, Nikki P., Wong, Chris K. C.
Publicado 2015

miR-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma

por Liu, Angela M., Xu, Zhi, Shek, Felix H., Wong, Kwong-Fai, Lee, Nikki P., Poon, Ronnie T., Chen, Jinfei, Luk, John M.
Publicado 2014

Anti-Cadherin-17 Antibody Modulates Beta-Catenin Signaling and Tumorigenicity of Hepatocellular Carcinoma

por Wang, Yonggang, Shek, Felix H., Wong, Kwong F., Liu, Ling Xiao, Zhang, Xiao Qian, Yuan, Yi, Khin, Ester, Hu, Mei-yu, Wang, Jian Hua, Poon, Ronnie T. P., Hong, Wanjin, Lee, Nikki P., Luk, John M.
Publicado 2013